Randomized phase II trial of capecitabine plus irinotecan (CapIri) vs capecitabine plus oxaliplatin (CaPox) as first line therapy of advanced colorectal cancer (ACRC). - Grothey,A.; Jordan,K.; Kellner,O. (Proc Am Soc Clin Oncol, 2003)